# Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial

> **NCT07393386** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 249 (estimated)

## Conditions studied

- Pain Management

## Interventions

- **DRUG:** Bupivacaine 0.125%
- **DRUG:** Bupivacaine 0.25%
- **DRUG:** Normal Saline
- **OTHER:** Multimodal Analgesia

## Key facts

- **NCT ID:** NCT07393386
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 249 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07393386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07393386, "Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07393386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*